Hologic is a global champion of women’s health. We integrate The Science of Sure into everything we do to help improve and save lives through early detection and proactive treatment.


Nam tincidunt felis ac arcu ultrices, a mattis lectus imperdiet. Sed suscipit suscipit consectetur. Nulla velit ante, molestie sit amet massa fringilla, rutrum venenatis purus. Fusce tempus tempus velit, quis malesuada quam accumsan non. Donec ornare, eros tincidunt aliquet iaculis, purus quam porta felis, non suscipit turpis nunc et elit. Donec sagittis dolor et nisi venenatis varius. Quisque accumsan eros mauris, condimentum tempor est ullamcorper non. Pellentesque interdum, odio eleifend hendrerit pellentesque, magna eros sagittis tellus, vitae pretium orci metus nec urna.


3Dimensions® Mammography System
A better 3D™ breast screening experience...
Acessa® Laparoscopic Radiofrequency Ablation (Lap-RFA)
The Acessa procedure is a minimally...
Aptima Combo 2® assay (for CT/NG)
STIs are on the rise. Chlamydia...
Aptima HPV +ThinPrep Cervical Health
Leading the charge in cervical disease...

3Dimensions® Mammography System

A better 3D™ breast screening experience – for everyone. The new 3Dimensions system is designed to provide higher quality 3D images for radiologists, a more comfortable mammography experience for patients and enhanced workflow for technologists. Discover how sharper images and smarter technologies continue to help find invasive cancers regardless of age or breast density.

Acessa® Laparoscopic Radiofrequency Ablation (Lap-RFA)

The Acessa procedure is a minimally invasive, outpatient treatment that involves two small abdominal incisions.1 It uses controlled radiofrequency energy, heat, to cause coagulative necrosis of the fibroid tissue. The treated tissue softens and shrinks over time, allowing fibroid symptoms to resolve with no suturing of the uterine tissue.

Aptima Combo 2® assay (for CT/NG)

STIs are on the rise. Chlamydia (CT) and gonorrhea (NG) can have serious long-term consequences including pelvic inflammatory disease (PID), ectopic pregnancy and infertility.1 Accurate testing and treatment are critical to protecting sexual and reproductive health. The Aptima Combo 2® assay delivers reliable results from multiple specimen types, including self and clinician-collected vaginal swabs with the Aptima® Multitest Swab — the preferred specimen type of the CDC for CT and NG testing.

Aptima HPV +ThinPrep Cervical Health

Leading the charge in cervical disease prevention with the ThinPrep® system and Aptima® HPV assays

Hologic has remained an unwavering advocate for women’s health for more than two decades. Our goals as a company are intrinsically tied to changes in best-practices for women’s health, applying the latest findings in diagnostic medicine to the development of new products and technologies in response to the emergence of new discoveries in medicine.

Aptima Multitest Swab Specimen Collection Kit

Women’s health testing streamlined with just one swab. With innovative nucleic acid amplification test (NAAT) technology and a single collection device, the Aptima Multitest Swab simplifies testing and provides more answers for sexual and vaginal health.

Aptima® CMV Quant Assay

FDA-Approved solution to reliably and efficiently deliver actionable viral load insights to post-transplant patients and their care teams.  

Aptima® HBV Quant Assay

Deliver trusted results with dual targets across a wide linear range and all major HBV genotypes.

Aptima® HCV Quant Dx Assay

Confirmation of active HCV infection and monitoring HCV viral load on the fully automated Panther® system.  

Aptima® Herpes Simplex 1 & 2 assay

NAATs, such as the Aptima® HSV 1 & 2 assay, are recommended by the CDC and WHO for HSV diagnosis. They are increasingly preferred over viral culture to diagnose genital herpes due to higher sensitivity, ease of specimen collection and transportation and faster results.2,3 The Aptima HSV 1 & 2 assay distinguishes between HSV-1 and HSV-2 with significant reduction in hands-on time for laboratory professionals when compared to culture and other instrument platforms.

Aptima® Herpes Simplex 1 & 2 assay

Globally, over 4.1 billion people are infected with HSV-1 and HSV-2 and the signs and symptoms can overlap.1 It is only through laboratory tests that these subtypes can be differentiated, which is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2,3
Aptima® HIV-1 Quant Dx Assay

Aptima® HIV-1 Quant Dx Assay

HIV-1 Detection and Viral Load Monitoring With performance you can count on, the Aptima HIV-1 Quant Dx assay is a dual-claim assay that can be used to confirm HIV-1 infection and measure viral load for optimal patient management.1 It offers reliable quantitation of HIV-1 RNA across a broad linear range, giving your lab excellent precision and sensitivity for HIV-1 detection and viral load monitoring.

Aptima® HIV-1 Quant Dx Assay

Dual-claim assay to confirm HIV-1 infection and measure viral load.

Aptima® HPV +ThinPrep® Cervical Health

Cervical disease screening is an essential component of our efforts in women’s health. Hologic is the leader in Pap and human papillomavirus (HPV) testing. The ThinPrep Pap test helps healthcare providers and laboratory professionals detect the presence of abnormal cervical cells, and the Aptima HPV assays identify high-risk HPV mRNA that is indicative of the HPV infections most likely to lead to cervical disease.1-3  

Know the Facts

The Pap test has been the most successful cancer screening program in history.4

The rate of cervical cancer, which was a leading cause of death among women, has fallen by more than 70 percent since the Pap test was introduced over 80 years ago.5 Previously, cervical cancer was the leading cause of cancer death in women, but now it is the fifteenth most frequent.

Reducing cervical cancer incidence requires a comprehensive strategy.

Such a strategy will include screening options that take into account disparities that underserved women face. This strategy should focus on reducing preventive screening gaps by:

  • Implementing provider and patient education
  • Providing access to vaccinations
  • Offering Pap + HPV (co-testing)

Aptima® Multitest Swab Specimen Collection Kit

With just one sample, the Aptima Multitest Swab simplifies testing and provides more answers for sexual and vaginal health.

Aptima® Mycoplasma genitalium Assay

Mycoplasma genitalium (M. gen) is an emerging health concern.
Testing for M. gen is recommended for all patients with recurrent urethritis, cervicitis and PID.1 Both women and men with M. gen infections are often asymptomatic and when left untreated, this infection can result in serious health consequences.

Aptima® STIs

STI testing for improved sexual health. The Aptima STI portfolio supports sexual health testing with a comprehensive, flexible menu of sexually transmitted infection (STI) assays.